Adjuvant mFOLFOX6 plus or minus cetuximab (Cmab) in patients (pts) with KRAS mutant (m) resected stage III colon cancer (CC): NCCTG Intergroup Phase III Trial N0147

Authors
Publication date
1 January 2010
Publisher
LVHN Scholarly Works

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Lehigh Valley Health Network: LVHN Scholarly Works

    redirect
    oaioai:scholarlyworks.lvhn.org:me...
    Last time updated on 15/12/2019